Peking — Beijing, Beijing Municipality

Public research footprint of Peking, compiled from the ClinicalTrials.gov public registry.

5,735

Registered studies

2,134

Active

1,278

Recruiting now

1,774

Completed

209

Stopped or withdrawn

Most-studied conditions

Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · Acute Myeloid Leukemia (AML) Relapse · HER2-positive Breast Cancer · Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Recently updated registry entries

NCT05091424 — A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a… (Recruiting)
NCT06790693 — A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and… (Recruiting)
NCT06895538 — Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Peking?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.